Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2023
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2023 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies.
The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals and agreements entered into by the worlds leading life science companies.
This report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date with the latest information, the report provides details of collaborative R&D deals from 2016 to 2023.
There has been a long standing willingness for parties to enter collaborative R&D deals. Such deals enable both parties to benefit from the upside of a big R&D win, whilst mitigating the risks of going it alone in the risky preclinical and clinical development stages.
Collaborative R&D is a specific type of partnering deal whereby the parties to the deal agree to collaborate on the research and development and subsequently commercialize a compound, product or technology.
There are several forms of a collaborative R&D deal; A traditional collaborative R&D arrangement whereby an owner of intellectual property (the licensor) provides access to its technology to another company (the licensee) in return for agreed payments and royalties on subscequent sales of product(s) derived from the intellectual property.
In more recent times, licensing is often the outcome of a successful period of collaborative R&D on the research and development of a technology or compound, resulting in a product which can be commercialized. In this situation, the collaborative R&D agreement governs who has permission to commercialize and what payments are due should commercialization proceed.
The report provides a detailed understand and analysis of how and why companies enter collaborative R&D deals. The majority of deals are multicomponent whereby the licensee retains either a right or option to license to comoercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all collaborative R&D deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaborative R&D contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of collaborative R&D dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in collaborative R&D as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of collaborative R&D deals. The chapter includes numerous case studies to enable understanding of both pure collaborative R&D deals and multicomponent deals where collaborative R&D forms a part.
Chapter 4 provides a review of the leading collaborative R&D deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a review of the top 25 most active biopharma companies in collaborative R&D. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 6 provides a comprehensive review of collaborative R&D financials for deals announced since 2016, including headline value, upfront, milestone payments and royalty rates, providing both benchmark data and access to individual deal financials.
Chapter 7 provides a comprehensive and detailed review of collaborative R&D deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.
The report also includes numerous table and figures that illustrate the trends and activities in collaborative R&D dealmaking since 2016.
In addition, a comprehensive appendix is provided organized by company A-Z, stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about collaborative R&D partnering in the research, development and commercialization of technologies and products.
Key benefits
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 provides the reader with the following key benefits:
- In-depth understanding of collaborative R&D deal trends since 2016
- Analysis of the structure of collaborative R&D agreements with real life case studies
- Comprehensive listing of over 6,000 collaborative R&D deals since 2016, together with deal terms, value and press release
- Comprehensive access to actual collaborative R&D contracts entered into by the world’s life science companies
- Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
- Insight into the terms included in a collaborative R&D agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Report scope
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 is intended to provide the reader with an in-depth understanding of the collaborative R&D trends and structure of deals entered into by leading life science companies worldwide.
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 includes:
- Trends in collaborative R&D dealmaking in the biopharma industry since 2016
- Analysis of collaborative R&D deal structure
- Case studies of real-life collaborative R&D deals
- Comprehensive listing of over 6,000 collaborative R&D deals since 2016
- Access to collaborative R&D contract documents
- Key financial benchmarks for headline, upfront, milestone and royalty rates
- The leading collaborative R&D deals by value since 2016
- Most active collaborative R&D dealmakers since 2016
- The leading collaborative R&D partnering resources
In Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 available deals and contracts are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.
The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive access to available contract documents for licensing deals. Analyzing actual contract agreements allows assessment of the following:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How do milestone align with clinical stage development phases?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2023 report provides the reader with the following key benefits:
- In-depth understanding of collaborative R&D deal trends since 2016
- Analysis of the structure of collaborative R&D agreements with real life case studies
- Comprehensive listing of all collaborative R&D deals since 2016, together with deal terms, value and press release
- Comprehensive access to actual collaborative R&D contracts entered into by the world’s life science companies
- Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
- Insight into the terms included in a collaborative R&D agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in collaborative R&D dealmaking
2.1. Introduction
2.2. Definition of collaborative R&D partnering
2.3. Success factors for collaborative R&D deals
2.4. When collaborative R&D can be useful
2.5. Attributes of collaborative R&D deals
2.6. Trends in collaborative R&D deals since 2016
2.6.1. Collaborative R&D dealmaking by year, 2016 to 2023
2.6.2. Collaborative R&D dealmaking by phase of development, 2016 to 2023
2.6.3. Collaborative R&D dealmaking by industry sector, 2016 to 2023
2.6.4. Collaborative R&D dealmaking by therapy area, 2016 to 2023
2.6.5. Collaborative R&D dealmaking by technology type, 2016 to 2023
2.6.6. Collaborative R&D dealmaking by most active company, 2016 to 2023
2.7. The future of collaborative R&D deals
Chapter 3 – Overview of collaborative R&D deal structure
3.1. Introduction
3.2. Pure versus multi-component collaborative R&D deals
3.3. Pure collaborative R&D agreement structure
3.3.1. Example collaborative R&D agreements
3.3.1.a. Case study 1
3.3.1.b. Case study 2
3.4. Collaborative R&D as part of a wider alliance agreement
3.4.1. Example collaborative R&D agreements and their licensing clauses
3.4.1.a. Case study 3
3.4.1.b. Case study 4
3.4.2. Example licensing option right clauses in collaborative R&D deals
3.4.2.a. Case study 5
3.4.2.b. Case study 6
Chapter 4 – Leading collaborative R&D deals
4.1. Introduction
4.2. Top collaborative R&D deals by value
Chapter 5 – Top 25 most active collaborative R&D dealmakers
5.1. Introduction
5.2. Top 25 most active collaborative R&D dealmakers
Chapter 6 – Collaborative R&D deal term financials
6.1. Introduction
6.2. Collaborative R&D partnering headline values
6.3. Collaborative R&D deal upfront payments
6.4. Collaborative R&D deal milestone payments
6.5. Collaborative R&D royalty rates
Chapter 7 – Collaborative R&D contract directory 2016 - 2023
7.1. Introduction
7.2. Collaborative R&D deals with contracts 2016 to 2023
Appendices
Appendix 1 – Collaborative R&D dealmaking by companies A-Z
Appendix 2 – Collaborative R&D dealmaking by industry sector
Appendix 3 – Collaborative R&D dealmaking by stage of development
Appendix 4 – Collaborative R&D dealmaking by therapy area
Appendix 5 – Collaborative R&D dealmaking by technology type
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
TABLE OF FIGURES
Figure 1: Definition of collaborative R&D
Figure 2: Situations where collaborative R&D can prove useful
Figure 3: Key attributes of a collaborative R&D deal
Figure 4: Trends in Collaborative R&D deal announcements, 2016 to 2023
Figure 5: Collaborative R&D deals signed at each phase of development, 2016 to 2023
Figure 6: Collaborative R&D deals by industry sector, 2016 to 2023
Figure 7: Collaborative R&D deals by therapy area, 2016 to 2023
Figure 8: Collaborative R&D deals by technology type, 2016 to 2023
Figure 9: Top 25 most active collaborative R&D dealmakers, 2016 to 2023
Figure 10: Collaborative R&D agreements – what should a contract include?
Figure 11: Components of the collaborative R&D deal structure
Figure 12: Top collaborative deals by value 2016 to 2023
Figure 13: Most active collaborative R&D dealmakers 2016 to 2023
Figure 14: Collaborative R&D deals with a headline value
Figure 15: Collaborative R&D deals with an upfront value
Figure 16: Collaborative R&D deals with a milestone value
Figure 17: Collaborative R&D deals with a royalty rate value
Pricing options
- $3,995: single-user
- $5,745: multi-user
- $10,995: single site license
- $17,995: global site license
A full explanation of license type definitions can be found here.
Our guarantee
Price promise
We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.
Delivery Deadline
We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)
Latest report
If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.
Serious Security
We take your data and security seriously. See our privacy policy for details of how we manage your data.
All card payments are processed by SagePay.
Sales Support
If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.
- Total Trust
Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.
1QBit, 1ST Biotherapeutics, 2bPrecise, 2cureX, 2seventy bio, 3 Sisters Surrogacy, 3B Medical, 3B Pharmaceuticals, 3Derm Systems, 3D Medicines, 3D Systems, 3M, 3SBio, 3Scan, 3T Biosciences, 4baseCare, 4B Technologies, 4C Biomed, 4D Molecular Therapeutics, 4D Path, 4D Pharma, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 10X Genomics, 22nd Century, 23andMe, 48Hour Discovery, 54gene, 111, 908 Devices, A*STAR Agency for Science, Technology and Research, A*STAR Bioprocessing Technology Institute, A*STAR Genome Institute of Singapore, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A.I. Squared, A2 Biotherapeutics, A3 Informatics, Aachen University, Aarhus University Hospital, AARP Healthcare, AavantiBio, AAVnerGene, AB2 Bio, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera Biologics, AbCheck, Abdul Latif Jameel Health, Abeome, Abera Bioscience, Abilita Bio, Ab Initio, Abintus Bio, ABL Bio, Ablexis, Ablynx, Ab Magnitude Ventures, AbMed, Abound Bio, Abpro, Abramson Cancer Center, Abreos Biosciences, AbSci, Absolute Antibody, Ab Studio, AbTis, Abu Dhabi Stem Cells Center, Abveris, Abzena, Academic and Community Cancer Research United, Academic Drug Discovery Consortium, Academic Medical Center, Academy of Nutrition and Dietetics, ACADIA Pharmaceuticals, AC Bioscience, Accelerated Cure Project for MS, Accelerated Enrollment Solutions, Accelerate Diagnostics, Accelerator for Technological Research in Genomic Therapies, Acceleron Pharma, Acceliant, Accellta, Accelovance, Accent Therapeutics, Accenture, Access Health, Access to Comprehensive Genomic Profiling Coalition, AccuGenomics, Accurate Diagnostic Laboratories, Accuray, Accurexa, AccurKardia, ACEA Biosciences, Acelrx Pharmaceuticals, Acentrus Specialty, Acerand Therapeutics, Acerta Pharma, Acer Therapeutics, aCGT Vector, Achaogen, Ache, Achieve Life Science, Acibadem University, AC Immune, Acoustic MedSystems, ACROBiosystems, Actelion, Acticor Biotech, Actigraph, Actinium Pharmaceuticals, Actome, ACT Therapeutics, Actu-Real, Actuate Therapeutics, Acucela, Acuity Pharmaceuticals, Acumen Analytics, Acurx Pharmaceuticals, Adagene, AdAlta, Adamis Pharmaceuticals, Adapsyn Bioscience, Adapt Analytics, Adaptate Biotherapeutics, Adaptiiv, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, Adaptive Research, Adcentrx Therapeutics, ADC Therapeutics, Addex Therapeutics, Addiction Institute of Mount Sinai, Adeptrix, Adicet Bio, Adimab, ADInstruments, Aditx Therapeutics, Adlai Nortye, ADL Bionatur Solutions, ADMA Biologics, Admera Health, ADM Tronics, AdoRx Therapeutics, Adrestia, Aduro BioTech, Advaccine Biotechnology, Advanced BioNutrition, Advanced Chemistry Development, Advanced Clinical, Advanced Clinical Trial Solutions, Advanced Proteome Therapeutics, AdvanSource Biomaterials, Advarra, Advaxis, AdventHealth, Adventist Health, Adverum Biotechnologies, Advocate Health Care, Adynxx, Aegea Biotechnologies, Aeglea BioTherapeutics, Aelis Pharma, Aequus Pharmaceuticals, Aerami Therapeutics, Aerie Pharmaceuticals, Aeromics, Aethlon Medical, Aetion, Aetna, Aetos Biologics, Aevi Genomic Medicine, AffaMed Therapeutics, Affilogic, Affimed Therapeutics, Affini-T Therapeutics, Affinia Therapeutics, AffyXell Therapeutics, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, AgaMatrix, AgBiome, AGC Asahi Glass, AGC Biologics, Age Labs, Agena Bioscience, Agendia, Agenus Bio, AgeX Therapeutics, AgileBio, Agilent Technologies, Agilis Biotherapeutics, Agios Pharmaceuticals, AgMedica Bioscience, AgonOx, AgPlenus, Agriplex Genomics, AgroSource, Aguettant, AHN Autoimmunity Institute, AIBody, Aichi Medical University, AiCure, AiCuris, Aidence, Aidoc, Aiforia Technologies, AIG Hospitals, AIkido Pharma, AIMA Laboratories, AimedBio, Aimmune Therapeutics, AINQA Health, AIon Labs, Aitbiotech, Ajinomoto, Akadeum Life Sciences, Akashi Therapeutics, Akcea Therapeutics, Akebia Therapeutics, Akeso Biopharma, AKESOgen, Akili Interactive Labs, AKL Research and Development, Akoya Biosciences, Akribis Systems, Akshaya Bio, AKSO Biopharmaceutical, Akston Biosciences, Alamar Biosciences, Albany Molecular Research, Alberta Health Services, Albert Einstein College of Medicine, Albertsons Companies, Albumedix, Alchemab, Alcyone Lifesciences, Alcyone Therapeutics, Aldevron, Aldeyra Therapeutics, Alector, Alectos Therapeutics, Aleph Objects, Aleris, Alessa Therapeutics, Aleta Biotherapeutics, Alexandria Venture Investments, Alexion Pharmaceuticals, Alex Therapeutics, Alex’s Lemonade Stand Foundation, Alfred E. Mann Institute for Biomedical Engineering, AlgaEnergy, Alibaba Health, Alienware, Aligos Therapeutics, AliHealth, Alimentiv, AlivaMab Discovery Services, AliveCor, ALK-Abello, Alkahest, Alkermes, Allegheny General Hospital, Allegheny Technologies, Allelica, Allen Institute for Brain Science, Allergan, AlleyCorp, Alliance for Clinical Research Excellence and Safety (ACRES), Alliance For Clinical Trials In Oncology, Alliance for Regenerative Medicine, Alliance Medical, Alligator Bioscience, Allm, Allogene Therapeutics, Alloplex Biotherapeutics, AlloSource, Allosteric Bioscience, Alloy Therapeutics, Allozymes, Allscripts, AllStripes, Almac Diagnostics, Almac Discovery, Almac Group, Almirall, Alnylam Pharmaceuticals, Alpha Biopharma, Alphageneron Pharmaceuticals, Alpha Genomix Laboratories, Alphalyse, Alphamab Biopharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, ALR Technologies, ALS Association, AltaML, Altasciences, Altavant Sciences, AltaVoice, AltemisLab, Altoida, Alto Neuroscience, Altor BioScience, Altreos Research Partners, Alveo Technologies, Alvotech, ALX Oncology, Alyzen Medical Physics, Alzheimer's Drug Discovery Foundation, Alzheon, AlzProtect, Amador Bioscience, Amal Therapeutics, Amarin, Amathus Therapeutics, Amazon Web Services, Ambergen, Ambiopharm, Ambrosia Nutraceuticals, Ambrx, Ambry Genetics, Ambys Medicines, AMC Health, AMD Insight, Amedica, American Academy of Ophthalmology, American Academy of Orthopaedic Surgeons, American Academy of Pediatrics, American Association for Cancer Research, American BriVision, American Cancer Society, American College of Cardiology, American College of Chest Physicians, American College of Radiology, American Dental Association, American Diabetes Association, American Gene Technologies, American Heart Association, American Liver Foundation, American Lung Association, American National Multiple Sclerosis Society, American Peptide Company, American Physiological Society, American Sleep Apnea Association, American Society for Parenteral and Enteral Nutrition, American Society of Clinical Oncology (ASCO), American Society of Gene and Cell Therapy, American Society of Hematology, American Type Culture Collection (ATCC), American Urological Association, American Well, Amerigen Pharmaceuticals, AMFitzgerald, Amgen, Amicus Therapeutics, Amneal Pharmaceuticals, Amolyt Pharma, Amorsa Therapeutics, Amoy Diagnostics, Amphilix, Amphista Therapeutics, Ampio Pharmaceuticals, Amplicon Express, AmpliPhi Biosciences, AmplyCell, AMR, AMRA, AMRA Medical, Amyris, Amytrx Therapeutics, AnaBios, Anaeropharma, Anagenesis Biotechnologies, Analog Devices, Analytical BioSciences, Analytics Engines, ANANDA Scientific, Anavex Life Sciences, AnchorDx, Andorra Development and Investment, Andor Technology, Andrew Alliance, Angers University, AnGes MG, Angiex, Angion Biomedica, Angsana Molecular & Diagnostics, AnHeart Therapeutics, Anika Therapeutics, Anima Biotech, AnimalBiome, Animal Clinical Investigation, Anixa Biosciences, Anji Pharma, Ankarys Therapeutics, Ankyra Therapeutics, Annapurna Therapeutics, Anokion, Anpac Bio-Medical Science, Ansys, Antaros Medical, Antengene, Anteo Diagnostics, Antheia, Anthem, Anthem Bluecross, Antibe Therapeutics, Antibiotic Research UK, Antidote, Antidote Therapeutics, Antigen Express, Antikor Biopharma, Antion Biosciences, Antleron, Anumana, Aon Group, ApconiX, Apeiron Biologics, Apellis Pharmaceuticals, Apexigen, Apex Physics Partners, Aphios, Aplastic Anemia & MDS International Foundation, Apocell, ApolloBio, Apollo Health, Apollomics, Apollo Therapeutics, Apotex, Appia Bio, Appili Therapeutics, Appistry, Apple, Applied BioMath, Applied Cells, Applied Clinical Trials, Applied DNA Sciences, Applied Genetic Technologies, Applied Nanoscience, Applied Spectral Imaging, Applied StemCell, AppliTek, Appriss Health, Aprea, Aprecia Pharmaceuticals, Apricity Health, Aprima Medical Software, APRINOIA Therapeutics, Aptamer Therapeutics, Aptar Pharma, Aptevo Therapeutics, Aptorum Group, APT Therapeutics, Aptuit, Aqemia, Aqilion, Aquinnah Pharmaceuticals, Aragen Bioscience, Aratana Therapeutics, Aravive Biologics, Arbor Biotechnologies, Arbutus, Arcadia Biosciences, Arc Bio, ARC Devices, ArcherDX, ARCHIMEDlife, Arctic Vision, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardena, Ardent Mills, Arecor, Arena Pharmaceuticals, Ares Genetics, Ares Life Sciences, argenx, Argobio, Argonne National Laboratory, Ariadne Genomics, Ariana Pharma, Aridis Pharmaceuticals, ArisGlobal, Arista Cereal Technologies, Arix Bioscience, Arizona State University, Arm, ArmaGen, Arnay Sciences, Aro Biotherapeutics, AroCell, Arpeggio Biosciences, Arquer Diagnostics, Arrakis Therapeutics, Arranta Bio, Array Biopharma, Arria, Arrowhead Pharmaceuticals, Arsenal Biosciences, ArtemiLife, Artes Biotechnology, ARTeSYN Biosolutions, Artialis, Artidis, Artificial, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, ARTMS Product, ARUP Laboratories, Aruvant Sciences, Arvinas, Arzeda, Asahi Kasei, Asahi Kasei Pharma America, Asan Medical Center, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, ASC Therapeutics, Asensus Surgical, Asher Biotherapeutics, Ashvattha Therapeutics, Asia-Pacific Hepatocellular Carcinoma Trials Group, Asieris MediTech, Asieris Pharmaceuticals, Asimily, ASKA Pharmaceuticals, AskAt, Asklepios Biopharmaceutical, Aslan Pharma, ASM International, Aspect Biosystems, Aspect Imaging, Assay.Works, AssayQuant Technologies, Assembly Biosciences, Association for the Advancement of Blood & Biotherapies, Association of Clinical Research Professionals, Assurea, Assurex Health, Assuta Medical Centers, Astellas Pharma, Astellas Pharma US, Astellas Venture Management, Astem, Asterand Bioscience, Astero Bio, Astex Pharmaceuticals, Asthma UK, AstraZeneca, Astute Medical, Asuragen, ATAI Life Sciences, Atalanta Therapeutics, Atara Biotherapeutics, Atavistik Bio, Atea Pharmaceuticals, aTen Therapeutics, Athenex, Athersys, Athos Therapeutics, Atila BioSystems, Atlab Pharma, Atlante Biotech, Atlas Venture, ATMPS, Atomwise, Atreca, Attana, ATUM, Atvio Biotech, aTyr Pharma, Auburn University, Audentes Therapeutics, Augusta University Health, AUM Biosciences, Aural Analytics, Auransa, Aurealis Therapeutics, Aurelius Biotherapeutics, Aurena Laboratories, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Auris Medical, Auron Therapeutics, AusHealth, Australian Research Data Commons, Autifony Therapeutics, Autigen, Autism Speaks, Autobahn Labs, Autodesk, Autolus, Automation Anywhere, Auxita, Auxly Cannabis Group, Avacta, Avalere Health, Avalon GloboCare, Avance Biosciences, AvantGen, Avantor, Avatamed, Avectas, Avellino Labs, AVEO Oncology, Avera Health, Avera Heart Hospital of South Dakota, Avery Therapeutics, Aviceda Therapeutics, Avicenna Technology, Avidity Biosciences, Avita Therapeutics, Avrobio, Axcelead Drug Discovery Partners, Axcella, AXIM Biotechnologies, Axiogenesis, Axis Therapeutics, Axol Bioscience, Axovant Gene Therapies, Axway, Axxam, Aytu BioPharma, Azra AI, B-MoGen Biotechnologies, Bacit, Bactevo, Baebies, Baheal Pharmaceutical, BAKX Therapeutics, BalGeunSeSang Eye Clinic, Bank of America, Banner Health, BaoDao Feed, Baptist Health Care, Barth Syndrome Foundation, Baruch S Blumberg Institute, Bascom Palmer Eye Institute, BASF, Basilea Pharmaceutica, Batavia Biosciences, Battelle, Bavarian Nordic, Baxalta, Baxter International, Bay Area Lyme Foundation, Bayer, Bayer CropScience, Bayer Healthcare, Bay Labs, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Health Care System, Baylor Miraca Genetics Laboratories, Bay State Milling Company, B Braun, BC Cancer Agency, BC Neuroimmunology, BC Platforms, BC Technical, Beacon Biosignals, Beacon Discovery, Beactica, Beam Therapeutics, Beck's, Beckman Coulter, Becton Dickinson, BeeKeeperAI, BehaVR, BeiGene, Beijing Genomics Institute (BGI), Beijing Illness Challenge Foundation, Beijing InnoCare Pharma, Beijing Tide Pharmaceutical, Belharra Therapeutics, Bellicum Pharmaceuticals, Ben-Gurion University, BenevolentAI, Benitec Biopharma, Benson Hill Biosystems, Berg, BERG Analytics, BerGenBio, Berkeley Lights, Berlinger, Beroni Group, Berry Genomics, Bertin Pharma, Beryl Institute, Beta Pharma, Beta Therapeutics, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Bethyl Laboratories, Better Therapeutics, Beyeonics Vision, Beyondspring Pharmaceuticals, Beyond Type 1, BGI, BGN Technologies, Bhami Research, BIA Separations, Bicycle Therapeutics, Bigfoot Biomedical, BigHat Biosciences, Bill and Melinda Gates Foundation, BIND Therapeutics, Bio-Cancer Treatment International, Bio-Me, Bio-Optronics, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, bioAffinity Technologies, BioAge Labs, BioAgilytix, BioAnalytical Systems, BioArctic Neuroscience, BioArdis, BioAscent Discovery, biOasis Technologies, BIOASTER, BioAtla, BioBlast Pharma, BioBright, BioCanRx, Biocare Medical, Biocartis, BioCentriq, Biocept, Bioceres, Biocon, BioCopy, BIOCORP, BioCurate, BioCure, Biocytogen, BioDerm, Biodesix, Biodextris, BioDigital, Biodirection, BioDiscovery, BioDuro, Bioforum, Biofourmis, Biogen, BioGenes, BioGenetics, Biognosys, BioGX, Bioharmony Therapeutics, Biohaven Pharmaceuticals, BioIntelliSense, BioInvent, BioIQ, BioLabs, BioLife Solutions, BiolineRX, BioLingus, BioLite Japan, BioLizard, Biolog-id, Biological Dynamics, BiologIC Technologies, biologistex CCM, Biolojic Design, BioLum Sciences, BioMagnetic Solutions, Biomanufacturing Training and Education Center, BioMap, Biomarck Pharmaceuticals, BioMarin Pharmaceutical, BioMark Diagnostics, Biomarker Collaborative, BiomeBank, Biomed, Biomed Elements, Biomedical Advanced Research and Development Authority, Biomedical Systems, Biomedix, BIOMEDX Group, BioMed X Innovation Center, Biomeme, bioMerieux, Biomica, Biomillenia, Biomodels, BioMotiv, BiomX, BioNano Genomics, Bionaut Labs, BiondVax, Bioneer, Bionetix, Bionic Sight, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BioOhio, Biopharmaceutical Research Company, BioPharma Plasma, BioPharmics, Biophore Pharmaceuticals, BioPontis Alliance, Bio Products Laboratory, Bioqube Ventures, BioRap Technologies, Biorchestra, BioReference Laboratories, BioRestorative Therapies, Biortus Biosciences, Biosceptre International, BioSense Global, Biosero, Bioserve, Bioservo Technologies, BioSig Technologies, Biosion, Biositu Pharmaceutical Technology, BioSolveIT, Biosortia Pharmaceuticals, BioSpherix, BioStrand, BioSurplus, BioSymetrics, Biotage, Biotechnology and Biological Sciences Research Council (BBSRC), BioTek Instruments, Biotem, Biotest, BioTheranostics, Biothera Pharmaceuticals, BioTheryX, Biotheus, Biotools, Biotop, Biotricity, Biotronik, BioVaxys, Bioventus, Bioverativ, BioVersys, BioVinc, BioXcel, Bioz, BirchBioMed, Bird Foundation, BiVictriX Therapeutics, Black Diamond Therapeutics, Blackford, Blackfynn, Blacksmith Medicines, Blackstone, BlackThorn Therapeutics, Blanver, Blockchain Global, Blood Centers of America, Blood Systems Research Institute, Bloom Science, Blu Biotech, Bluebird Bio, Bluebridge Technologies, Blue Cross Blue Shield Association, Blue Earth Diagnostics, Bluejay Diagnostics, Blue Mesa Health, Blue Note Therapeutics, BluePen Biomarkers, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Blue Shield of California, Blum Center for Health, BluSense Diagnostics, BMC Medical, Boca Biolistics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bohai Biomedical, Bolt Biotherapeutics, Bolt Threads, Bonbouton, Bone Therapeutics, Bonnie J. Addario Lung Cancer Foundation, Boomer Esiason Foundation, Bophelo Bioscience & Wellness, BostonGene, Boston Scientific, Boston Therapeutics, Boston University, Bota Bio, BPL Medical Technologies, Bracco Imaging, Brain and Spine Institute, Brain Balance Achievement Centers, BRAINBox Solutions, BrainLAB, Brainomix, Brain Research Through Advancing Innovative NeurotechnologiesInitiative, Brain Scientific, BrainStorm Cell Therapeutics, Brain Trauma Foundation, Brain Treatment Center San Diego, BravoVax, Breath Diagnostics, BriaCell Therapeutics, BrickBio, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, BridGene Biosciences, Brigham and Women's Hospital, BrightFocus Foundation, Bright Giant, BrightInsight, Bright Peak Therapeutics, Brightseed, Brii Biosciences, Bristol-Myers Squibb, Bristol-Myers Squibb Pakistan, British Lung Foundation, Broad Institute, Broncus Technologies, Brooks Automation, Brown University, Bruker, Bruker Daltonics, BTG, Buck Institute for Age Research, Bugworks, BullFrog AI, Burnet Institute, BurstIQ, Butantan Institute, Butterfly Network, BVI Medical, BYOMass, Byondis, C-Tri, C2i Genomics, C2N Diagnostics, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Cadent, Cadila Pharmaceuticals, Caelum Biosciences, Caerus Strength, Calcimedica, Caldera Pharmaceuticals, Calico, Calidi Biotherapeutics, California College of Natural Medicine, California Cryobank, California Institute for Biomedical Research, California Institute of Technology, California Life Sciences Association, Calithera Biosciences, Calixar, Calypso Biotech, Calyxt, Camargo Pharmaceutical Services, Cambia Health Solutions, Cambium Biomaterials, Cambridge Brain Sciences, Cambridge Cancer Genomics, Cambridge Consultants, Cambridge Epigenetix, Cambridge MedSpace, Cambridge Quantum Computing, CAMP4 Therapeutics, Can-Fite BioPharma, Canadian Cancer Society, Canadian Cancer Trials Group, Canary Health Technologies, CANbridge Pharmaceuticals, CancerCare, Cancer Genetics, Cancer Hospital Chinese Academy of Medical Sciences, CancerLinQ, Cancer Molecular Diagnostic Laboratory, Cancer Research Institute, Cancer Research Technology, Cancer Research UK, Cancer Science Institute of Singapore, CanCure, Candela, Candel Therapeutics, Cannabics Pharmaceuticals, Cannabis Science, CannaKids, Cannassure Therapeutics, Canndeo, Cannika, Canntab Therapeutics, CannTrust, Canopy Growth, Capillary Biomedical, Capitainer, Capricor Therapeutics, Caprion Biosciences, Caprisa, Capsida Biotherapeutics, Capsigen, Captor Therapeutics, Cara Care, Caravan Biologix, Caraway Therapeutics, CARB-X, Carbiotix, Carbon, Cardea Bio, CardieX, Cardiff Oncology, Cardiff University, Cardinal Health, CardioNXT, Cardio Renal Society of America, Cardiovascular Research Foundation, Cardiovascular Systems, Cardurion Pharmaceuticals, Care Access Research, CareDx, CareFirst BlueCross BlueShield, CareNet, Carepay, CarePoint Health, Carestream Health, Caresyntax, Cargill, Caribou Biosciences, Carilion Clinic, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carlsmed, Carl Zeiss, Carmentix, Carmine Therapeutics, Carmot Therapeutics, Carna BioSciences, Carnegie Mellon University, Carolina BioOncology Institute, Carrum Health, CarThera, Cartherics, CAS, Casdin Capital, Casebia Therapeutics, Case Western Reserve University, Casma Therapeutics, Castle Biosciences, Castle Creek Biosciences, CasZyme, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catalyst Pharmaceutical Partners, Catamaran Bio, Catholic University Leuven, cbdMD, CB Scientific, CB Therapeutics, CBT Pharmaceuticals, CDISC, CDR-Life, Ceapro, Cedars-Sinai Medical Center, Cegedim, CEITEC, Celanese, Celcuity, Celdara Medical, Celeri Health, CelerisTx, Celgene, Cell2in, CellAct, Cell and Gene Therapy Catapult, Cellares, Cellaria Biosciences, CellCarta, Cell Cure Neurosciences, Cell Design Labs, Cellectar Biosciences, Cellect Biotechnology, Cellectis, Cellectricon, Cellenkos, Cellesce, Cellevolve Bio, CellGenix, Cellibre, Celling Biosciences, CELLINK, Cellistic, CellMark Medical, Cell Medica, Cell Mogrify, CellOrigin Biotech, CellPoint, CellSight Technologies, Cell Signaling Technology, CellSpring, Cellthera Pharma, Cell Therapy Catapult, Cell Therapy Manufacturing Center, Cellular Biomedicine, Cellular Dynamics International, Cellworks, Celmatix, Celonic, Celsius Therapeutics, Celularity, Celyad, Cend Therapeutics, Censo Biotechnologies, CenSyn, Centauri Therapeutics, Centene, Center for Biomarker Research in Medicine, Center for Breakthrough Medicines, Center for Genomic Regulation, Center for Health Affairs, Center for Infectious Disease Research, Center on Addiction, Center Point Clinical Services, Centers for Disease Control and Prevention, Centessa Pharmaceuticals, Centogene, Central Admixture Pharmacy Services, Centre for Addiction and Mental Health, Centre for Cellular and Molecular Platforms, Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Drug Research and Development (CDRD), Centre for Research in Agricultural Genomics, Centre for Structural Systems Biology, Centre For The Commercialization Of Antibodies And Biologics, Centre Hospitalier Universitaire Vaudois (CHUV), Centre International de Developpment Pharmaceutique, Centre Leon Berard, Centro de Tecnologia Canavieira, Century Therapeutics, Cepheid, Cerba HealthCare, Cerebain Biotech, CerebraCell, Cerebral, Cerebras Systems, CereScan, Cerevance, Cerevel Therapeutics, Cergentis, CERIMED, Cerner, Cernostics, Certainty Health, Certara, CerTest Biotec, Certis, Cerveau Technologies, Cevec Pharmaceuticals, CFTechnology.org, CgBio, CHA Medical Group, Chamishi Therapeutics, Champalimaud Foundation, Champion Healthcare, Champions Oncology, Chao Center, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Associates, Charles River Laboratories, Chattanooga Center for Neurologic Research, CHDI Foundation, Check-Cap, Checkmate Pharmaceuticals, Checkpoint Therapeutics, ChemAxon, Chembio Diagnostics, ChemDiv, ChemGenes, ChemoCentryx, Chemspace, Chemveda Life Sciences, CHF Solutions, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Michigan Foundation, Children's Hospital of Philadelphia, Children's Hospital of Pittsburgh, Children's Medical Research Institute, Children's Mercy Hospital, Children's Minnesota, Children's National Health System, Children’s Center for Cancer and Blood Diseases (CCCBD), Chiltern, China Biotech Services, China Certification & Inspection Group, China Resources Pharmaceutical Commercial Group International Trading, China Southeast University, Chinese Academy of Agricultural Science, Chinese Academy of Sciences, Chinese Society of Cardiology, Chinese University of Hong Kong, Chinook Therapeutics, Chiome Bioscience, ChiScan, Chonnam National University, Chr Hansen, Christiana Care Health System, Christie Medical, Christus Health, ChromaTan, Chronix Biomedical, Chronolife, Chronos Therapeutics, Chugai Pharmaceutical, Chugai Pharma Marketing, CIC Health, Cidara Therapeutics, Cigna Healthcare, Ciitizen, Cilag AG, Cincinnati Children’s Hospital Medical Center, Ciox Health, Cipherome, Cipla, Circassia, Circle Pharma, Circuit Clinical, Circuit Therapeutics, CIRION BioPharma Research, Cirqle Biomedical, CISCRP, Citizens United for Research in Epilepsy, City of Hope, CIVCO Radiotherapy, Civica Rx, CJ CheilJedang, CK Life Sciences, Clalit Health Fund, Clarity Pharmaceuticals, CLEAR, Clearbridge Biomedics, Clear Creek Bio, ClearLight Diagnostics, Clearmind Medicine, ClearPath, ClearPoint Neuro, Cleveland Clinic, Cleveland University Hospitals, CLEW Medical, Click Therapeutics, Clinerion, Clinical Conductor, Clinical Development Services Agency, Clinical Genomics, Clinical Ink, Clinical Laserthermia Systems (CLS), ClinicAll International, Clinical Outcomes Tracking and Analysis, ClinicalStudyDataRequest, Clinical Study Support, Clinica Universidad Navarra, Clinigen, ClinOne, Clinton Health Access Initiative, Cloaked Therapeutics, Clorox Company, Close-Up International, Cloudera, Cloud Pharmaceuticals, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CLX Health, CMAB Biopharma, CMDC Labs, CMG Pharmaceutical, CMIC, CM Life Sciences, CMS Aesthetics, CMS Medical, CMT Research Foundation, CNAO Foundation, CN Bio, Coala Life, Coalition for Epidemic Preparedness Innovations, Coalition for the Advancement of Research and Innovation in Trauma, Coave Therapeutics, Cobra Biologics, Cochin Hospital, Cocoon Biotech, Cocrystal Pharma, Codagenix, Code Biotherapeutics, Code Ocean, Codex DNA, Codexis, Codiak BioSciences, Codigo46, COFCO Group, Cognate BioServices, Cognition Kit, Cognito Therapeutics, Cognizant, CogState, CohBar, Cohen Veterans Bioscience, Cold Genesys, Cold Spring Harbor, Colgate Palmolive, Collaborative Drug Discovery, Collaborative Trajectory Analysis Project, Collective Medical, Collplant, Colombia Ministry of Health and Social Protection, Color, Colorado Melanoma Foundation, Colorado School of Mines, Colorado State University, Colorcon, Columbia Care, Columbia University, Columbia University Medical Center, Colzyx, Community Clinical Oncology Research Network, Compact Imaging, Companion Medical, Compass Minerals Plant Nutrition, Complix, Compugen, CompuGroup Medical, Conatus Pharmaceuticals, Concept Life Sciences, ConcertAI, Concert Genetics, Concordia University, Concr, Cone Health, Confluent Medical Technologies, Confo Therapeutics, Congenica, ConserV Bioscience, Consortia Health Clinical Continence Services, Contera Pharma, Context Therapeutics, ContraVir Pharmaceuticals, ConvaTec, Convelo Therapeutics, Cook Biotech, Cooperative Research Centre for Cell Therapy Manufacturing, Copan Diagnostics, COPD Foundation, Coracoid Solutions, Corbin Therapeutics, Corbus Pharmaceuticals, CoreBiome, CoreRx Pharma, Corestem, Coriell Life Sciences, Coriolis Pharma Research, Cornell University, Corning, Corporation for Biological Research, Cortechs.ai, Corteva Agriscience, Cortex Design, Corvus Pharmaceuticals, CosmosID, COTA, Courtagen Life Sciences, Covance, Covaris, Covar Pharmaceuticals, CPI International, CPR Pharma Services, Creative Destruction Lab, Creative Medical Technologies, Creoptix, Crescendo Biologics, Crescendo Bioscience, Crescita Therapeutics, Cresset, Cricket Health, CRISPR Therapeutics, Cristal Therapeutics, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, CROMA Pharma, CromSource, Crossbeta Biosciences, Crosscope, Crown Bioscience, CR Pharma, CRS Bio, CryoPort, CrystalGenomics, CrystecPharma, CSafe Global, CSIR - Institute of Microbial Technology, CSL, CSL Behring, CSL Plasma, CSSI LifeSciences, CStone Pharmaceuticals, CTC Clinical Trial, CTD Holdings, CTX Technology, CUBRC, Cue Biopharma, Cullinan MICA, Cullinan Oncology, Cultivar Holdings, Cumberland Emerging Technologies, Cumming, Cummins, Curable, Curacle, Curadev Pharma, Curadigm, Curant Health, Curasan, Curative, Curebase, CureCell, Cure Duchenne, Cure Genetics, CureMatch, CureMetrix, CURE Pharmaceutical, Cure Sanfilippo Foundation, Curetis, CureVac, Curia, Curing Kids Cancer, Curis, Curium, Current Health, CurveBeam AI, CvergenX, CVie, CVS Caremark, CW Analytical, Cyagen Biosciences, CyberHeart, Cybin, Cybrexa Therapeutics, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclerion Therapeutics, Cyclica, Cyclo Therapeutics, CymaBay Therapeutics, Cynapsus Therapeutics, Cynergi Health Partners, CynergisTek, Cypre, Cyrus Biotechnology, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Cytapex Bioinformatics, Cytecare Cancer Hospitals, Cytel, cytena, Cytiva, CYTLIMIC, Cytobank, Cytocom, CytoLynx Therapeutics, CytomX Therapeutics, Cytoo, CytoReason, Cytos Biotechnology, CytoSen Therapeutics, Cytovance Biologics, Cytovant Sciences, CYTOVIA Therapeutics, Cytox, Cyxone, D. E. Shaw Research, D2M, d3 Medicine, DAAN Bio Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dako, Dalberg, Dalriada Drug Discovery, Dana-Farber Cancer Institute, DanausGT Biotechnology, Danish Cancer Society Research Center, Danish Center for Strategic Research into Type 2 Diabetes, Dante Labs, Dare Bioscience, DarioHealth, Dartmouth-Hitchcock Medical Center, DaRui Biotech, DarwinHealth, Dassault Systems, DataRobot, DATATRAK International, Datavant, Datos Health, David H. Koch Institute for Integrative Cancer Research, Da Volterra, Daxor, Day One Biopharmaceuticals, DayTwo, DBV Technologies, DCPrime, DEARhealth, Debiopharm, DEBRA Austria, Decernis, Decibel Therapeutics, Deciphex, deCODE Genetics, Decode Health, Dedalus Group, DEEP 6 AI, DeepCDR Biologics, Deep Cube, Deep Genomics, Deep Lens, Deep Longevity, Deep Science Ventures, Deerfield Management, Defense Advanced Research Projects Agency, Definiens, Definition Health, Defymed, Deinove, Delcath Systems, Delix Therapeutics, DelMar Pharmaceuticals, DelSiTech, Delta 4, Delve Health, DemDx, Dementia Discovery Fund, Denali Therapeutics, Denovium, Densitas, Dent Neurologic Institute, Dentsply International, Department of Defence, Department of Defense, Department of Health and Human Services, Department of Veterans Affairs, DePuy, Dermala, DermaPort, DermTech, Desktop Genetics, DestiNA Genomics, Devana Solutions, Dewpoint Therapeutics, DexCom, DHR Health, Diabetes Research Institute, Diabetes Singapore, Diaceutics, Diagnostic Robotics, DiA Imaging Analysis, DiaMedica, DiamiR, Diamond Light Source, Diamyd Medical, Diasend, DiaSorin, DiCE Molecules, Dicerna Pharmaceuticals, Dicom Systems, DigiLab, Digital Diagnostics, Digital Medicine Society, Digital Therapeutics Alliance, DILIsym Services, Dimension Therapeutics, DiNAQOR, Diopsys, DIOSynVax, Disability Solutions, DiscoveRx, Disior, Dispersive Technologies, Distributed Bio, Diverse Biotech, Diversigen, Dixie State University, DMTC, DNA Link, DNAnexus, DNA Script, DNAtrix, DNX Biopharmaceuticals, doc.ai, DoctorsOne Healthcare Systems, Dogma Therapeutics, Dolomite Bio, Domainex, Domain Therapeutics, Donald Danforth Plant Science Center, Dong-A ST, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dotmatics, DoubleRainbow Biosciences, Dow AgroSciences, Dow Chemical, Dow Jones, Dr. Agarwal’s Eye Hospitals, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Draper Laboratories, Drawbridge Health, DrChrono, DreaMed Diabetes, Drexel University, DrFirst, DrugDev, Drugs for Neglected Diseases Initiative, DSM, Duality Biologics, Dualogics, Dualsystems Biotech, Dual Therapeutics, Ductor, Duke-NUS Graduate Medical School Singapore, Duke Cancer Institute, Duke Clinical Research Institute (DCRI), Duke University, Duke University Health System, Duke University Medical Center, Dunad Therapeutics, DuPont, DuPont Pharmaceuticals, DxTerity, Dyadic International, DyNAbind, Dynacure, Dynasil, Dynavax Technologies, Dyno Therapeutics, Dystonia Medical Research Foundation, Dystrophic Epidermolysis Bullosa Research Association of America, DZNE German Center for Neurodegenerative Diseases, E-Therapeutics, E.I. Medical Imaging, E.T. Horn, Eagle Genomics, EA Pharma, EarlySense, Early Signal Foundation, East and North Hertfordshire NHS Trust, EBM-Solutions, EB Research Foundation, EB Research Partnership, Eccrine Systems, EC Healthcare, EchelonDx, Echosens, eClinicalHealth, ECOG-ACRIN Cancer Research Group, Edelris, Edesa Biotech, Edico Genome, EdiGene, Editas Medicine, EditForce, Edith Wolfson Medical Center, Edwards Lifesciences, eemagine, eFFECTOR Therapeutics, eGenesis, EHang Holdings, Eigen, Eiger BioPharmaceuticals, Eikonizo Therapeutics, Eisai, Eisai Inc, Eisana, EKF Diagnostics (Germany), Eko, Elaaj Bio, Elanco, Elastos Foundation, ELC Group, Electromedical Technologies, Elekta, Elektrofi, Elemental Machines, Element Biosciences, Elements of Genius, ElevateBio, Elevation Oncology, Elevian, Eliaz Therapeutics, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elix, Elligo Health Research, Ellume, Elo Life Systems, Elpiscience, Elsevier, Elucidata, Elucigene, Elysium Health, Embark Biotech, EmbodyBio, EMD Serono, Emedgene, Emendo Biotherapeutics, Emerge Health, Emergence Therapeutics, Emergent BioSolutions, Emergex Vaccines, Emirates Diabetes Society, Emmaus Life Sciences, Emocha Mobile Health, eMolecules, Emory University, Empatica, Emperra, Empirico, Emulate, Enable Biosciences, Enamine, Enara Bio, EnBiotix, Encoded Therapeutics, EncrypGen, Endevica Bio
For a full list of companies please contact us on enquiry@currentpartnering.com
Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.
The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant
Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.
